Although we considered the rationale for IL-7-containing vaccines specifically in MCC, our data provide a rationale for replicating this approach in other antigen-containing tumor vaccines to improve T cell expansion and durable immunologic memory. This evidence concerns the gene IL7 and Merkel cell skin cancer.